PO.TB10.14 · 肿瘤生物学
配对宏基因组分析揭示头颈癌患者口腔中部位特异性的微生物组成和保守的多样性
Paired metagenomic profiling reveals site-specific microbial composition and conserved diversity in the oral cavity of head and neck cancer patients
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:微生物多样性和组成在个体内不同口腔亚部位之间的变异程度仍未得到充分界定,这限制了基于微生物组的生物标志物的可重复性以及采样策略的标准化。我们研究了配对扁桃体和唾液样本之间的组成和多样性差异,以刻画HNC患者各口腔区室的微生物生态。
方法:从25例确诊为头颈部鳞状细胞癌的患者(NCT05142033)中采集了配对的扁桃体和唾液样本(中位年龄=63岁[IQR 53-73];76%为男性,96%为白人)。该队列包括68%口腔、20%口咽、8%喉部和4%皮肤原发。对所有样本进行了鸟枪法宏基因组测序。使用基于Bray-Curtis相异度矩阵的配对置换多元方差分析(PERMANOVA)评估beta多样性,并采用受限置换以考虑个体差异。使用配对Wilcoxon符号秩检验并进行错误发现率(FDR)校正来检验物种水平的差异丰度。此外,还比较了各部位之间的alpha多样性指标。
结果:扁桃体和唾液样本之间的微生物组成存在显著差异(PERMANOVA:F=1.00,R²=2.0%,p=0.001)。经FDR校正后,有20个物种表现出显著的丰度差异(q<0.05)。15个物种在唾液中相对扁桃体增加,包括Rothia aeria(FDR=0.004)、Actinomyces naeslundii(FDR=0.008)和Streptococcus sanguinis(FDR=0.009)。5个物种在唾液中减少,包括Prevotella scopos、Prevotella jejuni和Campylobacter concisus。尽管组成存在差异,但各部位之间的alpha多样性指标相当(Shannon指数:扁桃体3.73±0.59对唾液3.71±0.70,p=0.565;观察到的物种数:3135±1567对3251±1228,p=0.708)。均匀度的个体水平差异与组成相异度显著相关(Spearman rho=0.450,p=0.024),表明多样性和组成在个体内共同变化。
结论:扁桃体和唾液蕴含着不同的微生物群落,但维持着相当的物种多样性水平。这一模式体现了口腔中的生态位保守性。配对研究设计对于检测这些差异至关重要,因为巨大的个体差异盖过了部位特异性效应。这些发现对于理解头颈癌中的口腔微生物组生态具有意义,并提示采样部位的选择对于基于微生物组的生物标志物发现至关重要。
查看英文原文 English abstract
Background : The extent to which microbial diversity and composition vary across oral subsites within an individual remains poorly defined, limiting the reproducibility of microbiome-based biomarkers and the standardization of sampling strategies. We investigated compositional and diversity differences between paired tonsil and saliva samples to characterize microbial ecology across oral compartments in HNC patients.
Methods : Paired tonsil and saliva samples were collected from 25 patients diagnosed with head and neck squamous cell carcinoma (NCT05142033) (median age = 63 years [IQR 53-73]; 76% male, 96% White). The cohort included 68% oral cavity, 20% oropharyngeal, 8% laryngeal, and 4% cutaneous primaries. Shotgun metagenomic sequencing was performed on all samples. Beta diversity was assessed using paired permutational multivariate analysis of variance (PERMANOVA) on Bray-Curtis dissimilarity matrices with restricted permutations to account for individual variation. Species-level differential abundance was tested using paired Wilcoxon signed-rank tests with false discovery rate (FDR) correction. Additionally, alpha diversity metrics were compared between sites.
Results : Microbial composition differed significantly between tonsil and saliva samples (PERMANOVA: F=1.00, R²=2.0%, p=0.001). Twenty species showed significant abundance differences after FDR correction (q<0.05). Fifteen species were increased in saliva versus tonsils, including Rothia aeria (FDR=0.004), Actinomyces naeslundii (FDR=0.008), and Streptococcus sanguinis (FDR=0.009). Five species decreased in saliva, including Prevotella scopos , Prevotella jejuni , and Campylobacter concisus . Despite compositional differences, alpha diversity metrics were equivalent between sites (Shannon index: tonsil 3.73±0.59 vs saliva 3.71±0.70, p=0.565; observed species: 3135±1567 vs 3251±1228, p=0.708). Individual-level differences in evenness significantly correlated with compositional dissimilarity (Spearman rho=0.450, p=0.024), indicating that diversity and composition co-vary within individuals.
Conclusions : Tonsil and saliva harbor distinct microbial communities yet maintain equivalent species diversity levels. This pattern demonstrates niche conservatism in the oral cavity. The paired study design was essential for detecting these differences, as massive individual variation dominated over site-specific effects. These findings have implications for understanding oral microbiome ecology in head and neck cancer and suggest that sampling site selection is critical for microbiome-based biomarker discovery.
利益披露 Disclosure
J. Tschetter, None..
M. Perrin, None..
D. Starks, None..
B. Solomon, None..
W. Spanos, None..
S. Viet, None..
C. Silvernail, None..
J. L. Petersen, None..
E. A. Ehli, None.
T. Meissner,
Illumina ).
Tempus AI ).
LabCorp ).
Cellworks ).
C. T. Finnicum, None.